Convenio Anual Seccion 214, 2017 Xxvii
abastecer medicamentos pacientes HGGB
14 oferente(s) participaron en esta licitación. El detalle de quién compitió y con qué oferta está en el registro oficial de Mercado Público.
Ver oferentes en Mercado Público →| Código | Fecha | Proveedor | Monto |
|---|---|---|---|
| 4309-570-SE19 | 29-01-2019 | Ascend Laboratories SpA | $1.862.826 |
| 4309-604-SE19 | 29-01-2019 | Ethon Pharmaceuticals Ltda. | $116.620 |
| 4309-8337-SE18 | 31-12-2018 | Winpharm SpA | $174.930 |
| 4309-8298-SE18 | 21-12-2018 | Laboratorios Recalcine S.A. | $3.691.380 |
| 4309-8210-SE18 | 19-12-2018 | Ethon Pharmaceuticals Ltda. | $166.600 |
| 4309-7912-SE18 | 19-12-2018 | Novartis Chile S.A. | $9.496.200 |
| 4309-8105-SE18 | 19-12-2018 | Ethon Pharmaceuticals Ltda. | $182.784 |
| 4309-7611-SE18 | 03-12-2018 | Laboratorios Recalcine S.A. | $1.727.880 |
| 4309-7434-SE18 | 27-11-2018 | Ethon Pharmaceuticals Ltda. | $64.260 |
| 4309-7410-SE18 | 26-11-2018 | Ascend Laboratories SpA | $2.284.800 |
| 4309-7098-SE18 | 13-11-2018 | Ethon Pharmaceuticals Ltda. | $166.600 |
| 4309-6815-SE18 | 22-10-2018 | Winpharm SpA | $116.620 |
| 4309-6756-SE18 | 19-10-2018 | Novartis Chile S.A. | $4.273.290 |
| 4309-6740-SE18 | 19-10-2018 | Laboratorios Recalcine S.A. | $1.727.880 |
| 4309-6644-SE18 | 17-10-2018 | Ascend Laboratories SpA | $2.227.680 |
| 4309-6655-SE18 | 17-10-2018 | Ethon Pharmaceuticals Ltda. | $71.400 |
| 4309-6589-SE18 | 12-10-2018 | Novartis Chile S.A. | $5.087.250 |
| 4309-6572-SE18 | 12-10-2018 | Laboratorios Recalcine S.A. | $1.570.800 |
| 4309-6620-SE18 | 12-10-2018 | Winpharm SpA | $116.620 |
| 4309-6502-SE18 | 11-10-2018 | Ethon Pharmaceuticals Ltda. | $88.822 |
| 4309-6475-SE18 | 09-10-2018 | Ascend Laboratories SpA | $2.570.400 |
| 4309-6063-SE18 | 25-09-2018 | Ethon Pharmaceuticals Ltda. | $166.600 |
| 4309-6000-SE18 | 12-09-2018 | Ascend Laboratories SpA | $321.300 |
| 4309-5918-SE18 | 10-09-2018 | Laboratorios Recalcine S.A. | $1.727.880 |
| 4309-5978-SE18 | 10-09-2018 | Winpharm SpA | $134.113 |
| 4309-5942-SE18 | 10-09-2018 | Novofarma Service S.A. | $246.330 |
| 4309-5914-SE18 | 10-09-2018 | Novartis Chile S.A. | $4.069.800 |
| 4309-5824-SE18 | 05-09-2018 | Itf Farma Chile S.A. | $21.420 |
| 4309-5809-SE18 | 05-09-2018 | Ethon Pharmaceuticals Ltda. | $70.615 |
| 4309-5304-SE18 | 13-08-2018 | Ethon Pharmaceuticals Ltda. | $166.600 |
| 4309-5173-SE18 | 01-08-2018 | Winpharm SpA | $122.451 |
| 4309-5133-SE18 | 01-08-2018 | Laboratorios Recalcine S.A. | $1.099.560 |
| 4309-5150-SE18 | 01-08-2018 | Novartis Chile S.A. | $4.069.800 |
| 4309-5152-SE18 | 01-08-2018 | Itf Farma Chile S.A. | $53.550 |
| 4309-5047-SE18 | 31-07-2018 | Ethon Pharmaceuticals Ltda. | $96.795 |
| 4309-4544-SE18 | 09-07-2018 | Laboratorios Recalcine S.A. | $1.335.180 |
| 4309-4552-SE18 | 09-07-2018 | Novartis Chile S.A. | $4.069.800 |
| 4309-4555-SE18 | 09-07-2018 | Itf Farma Chile S.A. | $42.840 |
| 4309-4423-SE18 | 04-07-2018 | Ethon Pharmaceuticals Ltda. | $219.198 |
| 4309-4382-SE18 | 03-07-2018 | Winpharm SpA | $122.451 |
| 4309-3726-SE18 | 05-06-2018 | Winpharm SpA | $46.648 |
| 4309-3693-SE18 | 04-06-2018 | Novartis Chile S.A. | $2.848.860 |
| 4309-3579-SE18 | 31-05-2018 | Ethon Pharmaceuticals Ltda. | $315.707 |
| 4309-3377-SE18 | 25-05-2018 | Laboratorios Recalcine S.A. | $1.558.234 |
| 4309-2757-SE18 | 26-04-2018 | Ascend Laboratories SpA | $3.262.266 |
| 4309-2713-SE18 | 25-04-2018 | Laboratorios Recalcine S.A. | $1.515.037 |
| 4309-2681-SE18 | 24-04-2018 | Novartis Chile S.A. | $545.353 |
| 4309-2628-SE18 | 23-04-2018 | Ethon Pharmaceuticals Ltda. | $332.367 |
| 4309-2552-SE18 | 20-04-2018 | Winpharm SpA | $75.803 |
| 4309-1973-SE18 | 26-03-2018 | Ascend Laboratories SpA | $4.380.390 |
| 4309-1976-SE18 | 26-03-2018 | Itf Farma Chile S.A. | $21.420 |
| 4309-1862-SE18 | 21-03-2018 | Ethon Pharmaceuticals Ltda. | $4.284 |
| 4309-1858-SE18 | 21-03-2018 | Ethon Pharmaceuticals Ltda. | $306.687 |
| 4309-1815-SE18 | 20-03-2018 | Winpharm SpA | $5.831 |
| 4309-1802-SE18 | 20-03-2018 | Laboratorios Recalcine S.A. | $1.055.578 |
| 4309-1799-SE18 | 20-03-2018 | Novartis Chile S.A. | $5.388.415 |
| 4309-1617-SE18 | 09-03-2018 | Novartis Chile S.A. | $1.357.278 |
| 4309-1408-SE18 | 02-03-2018 | Winpharm SpA | $17.493 |
| 4309-1378-SE18 | 01-03-2018 | Laboratorios Recalcine S.A. | $1.107.414 |
| 4309-1296-SE18 | 28-02-2018 | Novartis Chile S.A. | $3.520.377 |
| 4309-1237-SE18 | 27-02-2018 | Ethon Pharmaceuticals Ltda. | $277.675 |
| 4309-1260-SE18 | 27-02-2018 | Ascend Laboratories SpA | $1.304.478 |
| 4309-783-SE18 | 31-01-2018 | Ascend Laboratories SpA | $856.800 |
| 4309-782-SE18 | 31-01-2018 | Winpharm SpA | $58.310 |
| 4309-781-SE18 | 31-01-2018 | Novartis Chile S.A. | $3.391.500 |
| 4309-786-SE18 | 31-01-2018 | Laboratorios Recalcine S.A. | $1.309.000 |
| 4309-785-SE18 | 31-01-2018 | Ethon Pharmaceuticals Ltda. | $371.685 |
Fuente original:ficha mercadopublico.cl
